Learn More
BACKGROUND The risks and benefits of coxibs, non-steroidal anti-inflammatory drugs (NSAIDs), and aspirin treatment are under intense debate. OBJECTIVE To determine the risk of peptic ulcer upper(More)
OBJECTIVES:After the withdrawal of some cyclooxygenase-2 (COX-2) selective inhibitors, traditional nonsteroidal anti-inflammatory drug (NSAID) use has increased, but without additional prevention(More)
BACKGROUND The use of tumour necrosis factor antagonists has changed the therapeutic approach to Crohn's disease. AIM To determine response and remission rates associated with the 4-week induction(More)